CaseXCase Series
Validating AI’s transformative impact in biologics discovery and development
An in-depth collection of case studies showing how LensAI™ powered by HYFT® technology is driving transformation.
These studies demonstrate AI’s role in supporting more efficient discovery processes, uncovering complex biologic insights, reducing development timelines, and informing better decision-making throughout discovery and development.
Key study:
LensAI Epitope Mapping matches X-ray crystallography
CaseXCase Series
Epitope Mapping
Case study collection:
Key study:
LensAI Epitope Mapping retains near X-ray precision on ‘unseen’ diverse clinically relevant complexes
CaseXCase Series
Epitope Mapping
Key study:
LensAI prediction of Anti-Drug Antibody incidence: evidence for clinical utility of ADA risk assessment
CaseXCase Series
Immunogenicity
Key study:
Antibody engineering for tumor microenvironment targeting
CaseXCase Series
Tumor Micro
Environment
Inside the AI and lab ecosystem redefining discovery
Part of a broader ecosystem that combines bio-native AI with a best-in-class lab—credited with advancing 15+ candidates to the clinic and achieving >98% success in leading B cell discovery.
Let’s discover your next breakthrough. With award-winning science and success-driven solutions, we help you move faster—with safer, more diverse candidates ready for the clinic.